| Gastrointestinal dysfunctions in Parkinson's disease: symptoms and treatments | 3,575 |
| Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation | 3,484 |
| DBS Programming: an evolving approach for patients with Parkinson's disease | 2,324 |
| LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson disease | 2,225 |
| Living with Parkinson's, the emerging role of occupational therapy. | 1,696 |
| Progressive resistance exercise and Parkinson's disease: A review of potential mechanisms | 1,651 |
| N-Acetyl Cysteine Protects against Methamphetamine-induced Dopaminergic Neurodegeneration via Modulation of Redox Status and Autophagy in Dopaminergic cells | 1,564 |
| Comparing the Mini-BESTest with the Berg Balance Scale to Evaluate Balance Disorders in Parkinson's Disease | 1,555 |
| METHAMPHETAMINE AND PARKINSON´S DISEASE | 1,456 |
| DOPAMINE OXIDATION AND AUTOPHAGY | 1,282 |
